Ra Medical Systems Inc

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Catheter Precision, Inc. engages in the design, manufacture and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for accurate positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins in September 2002 and is headquartered in Fort Mill, SC.

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical System to host webcast discussing the role of excimer lasers in the treatment of psoriasis during the pandemic

Ra Medical Systems to Host Webcast Discussing the Role of Excimer Lasers in the Treatment of Psoriasis during the Pandemic

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems Hosts Summit with Vascular Physicians to Monitor Progress on Next-Generation DABRA Catheter Design

Ra Medical Systems Hosts Summit with Vascular Physicians to Monitor Progress on Next-Generation DABRA Catheter Design

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report third quarter 2020 financial results and provide a business update after market close on Thursday, November 12, 2020. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.   Pre-Registration Participants can pre-register for the conference call using the foll

Ra Medical Systems to Report Third Quarter 2020 Financial Results on November 12, 2020

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces enrollment of the 10th subject in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). “Patient screening and enrollment have recently increased with five clinical

Ra Medical Systems Announces 10 Subjects Have Been Enrolled in its DABRA Pivotal Atherectomy Clinical Trial

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.

Ra Medical Systems to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 16

Ra Medical Systems, Inc. (RMED) CEO Jonathan McGuire on Q2 2020 Results - Earnings Call Transcript

Shares of Ra Medical Systems (NYSE:RMED) decreased 9.56% in after-market trading after the company reported Q2 results.

Recap: Ra Medical Systems Q2 Earnings

Ra Medical Systems, Inc. (RMED) delivered earnings and revenue surprises of -152.94% and 125.00%, respectively, for the quarter ended June 2020.

Ra Medical Systems, Inc. (RMED) Reports Q2 Loss, Tops Revenue Estimates

Ra Medical Systems Reports 2020 Second Quarter Financial Results

Ra Medical Systems to Report Second Quarter 2020 Financial Results on August 11, 2020

Ra Medical Systems Announces Closing of $12.0 Million Upsized Public Offering

Ra Medical Systems Announces Pricing of $12.0 Million Upsized Public Offering

LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED) concerning whether the board breached its fiduciary duty to shareholders. If you are a shareholder, click here for more information. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Ra Medical securities, have information or would like to learn more about these claims, or ha

The Law Offices of Frank R. Cruz Announces Investigation of Ra Medical Systems, Inc.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED). On March 14, 2019, the Company disclosed 4Q2018 revenue significantly below projections due to sales personnel staffing issues and certain production limitations, assuring investors that the issues had been resolved. Then, on August 12, 2019, t

RA MEDICAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED

NEW ORLEANS, May 22, 2020 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED). On March 14, 2019, the...

RA MEDICAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2020 Results - Earnings Call Transcript

Ra Medical Systems Inc (RMED) delivered earnings and revenue surprises of -166.67% and -9.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Ra Medical Systems Inc (RMED) Reports Q1 Loss, Misses Revenue Estimates

American States Water

BGC Partners

Eloxx Pharmaceuticals Inc

SharpSpring

These five stocks are poised to grow with the guidelines laid out to reopen the economy, as coronavirus pandemic dissipates.

5 Stocks to Gain the Most With the Economy Set to Reopen

Ra Medical Systems' (RMED) Management on Q4 2019 Results - Earnings Call Transcript

Ra Medical Systems' (RMED) CEO Dean Irwin on Q1 2019 Results - Earnings Call Transcript

Ra Medical Systems, Inc. (RMED) CEO Dean Irwin on Q4 2018 Results - Earnings Call Transcript

News for Ra Medical Systems Inc Stock (RMED)